Eversept Partners, LP

Source: SEC Form 13F · as of Mar 2026

Eversept Partners, LP holds 62 biotech & pharma companies tracked by BioSniper, totaling $984.3M in value as of Mar 2026 (SEC Form 13F).

Companies held

62

Total value held

$984.3M

CompanySharesValue
UTHRUNITED THERAPEUTICS Corp264,271$156.7M
ABVXAbivax SA934,423$104.0M
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)1,785,175$98.5M
VERAVera Therapeutics, Inc.2,173,286$87.4M
PCVXVaxcyte, Inc.924,193$53.7M
IONSIONIS PHARMACEUTICALS INC632,100$47.5M
QGENQIAGEN N.V.1,021,630$40.9M
VRTXVERTEX PHARMACEUTICALS INC / MA90,000$40.2M
BCRXBIOCRYST PHARMACEUTICALS INC3,039,820$28.9M
LQDALiquidia Corp677,392$25.6M
LLYELI LILLY & Co19,000$17.5M
TVTXTravere Therapeutics, Inc.542,610$16.1M
INSMINSMED Inc94,000$15.4M
CTMXCytomX Therapeutics, Inc.3,188,514$15.0M
RGENREPLIGEN CORP120,785$14.2M
BBNXBeta Bionics Inc.1,414,838$14.2M
VRDNViridian Therapeutics, Inc.\DE713,269$14.0M
ARQTArcutis Biotherapeutics, Inc.576,580$13.6M
ARDXARDELYX, INC.2,229,446$13.4M
BMRNBIOMARIN PHARMACEUTICAL INC207,768$11.7M
PHVSPharvaris N.V.406,960$11.5M
UNHUnitedHealth Group Incorporated Common Stock (DE)40,000$10.8M
NAMSNEWAMSTERDAM PHARMA CO N.V.285,764$9.1M
MRNAModerna, Inc.159,708$8.1M
VKTXViking Therapeutics, Inc.239,110$7.8M
ICLRICON plc68,688$7.6M
XENEXenon Pharmaceuticals Inc.129,574$7.5M
AGIOAGIOS PHARMACEUTICALS, INC.200,000$6.8M
GPCRStructure Therapeutics Inc.138,036$6.7M
TECHBIO-TECHNE Corp125,896$6.6M
MDGLMADRIGAL PHARMACEUTICALS, INC.10,000$5.2M
PRAXPraxis Precision Medicines, Inc.14,800$4.8M
ESPREsperion Therapeutics, Inc.1,735,963$4.8M
MOHMolina Healthcare Inc32,811$4.4M
DAWNDay One Biopharmaceuticals, Inc.183,902$3.9M
CMPSCOMPASS Pathways plc677,924$3.7M
DFTXDefinium Therapeutics Inc.160,723$3.0M
REPLReplimune Group, Inc.386,861$3.0M
IVVDInvivyd, Inc.2,276,349$3.0M
ALECAlector, Inc.1,351,106$2.9M
ANROAlto Neuroscience, Inc.125,168$2.8M
RLAYRelay Therapeutics, Inc.270,705$2.7M
LBRXLB PHARMACEUTICALS INC100,198$2.5M
VIRVir Biotechnology, Inc.250,000$2.2M
SVRASavara Inc384,264$2.1M
RLMDRELMADA THERAPEUTICS, INC.277,899$1.9M
STROSUTRO BIOPHARMA, INC.73,161$1.8M
SRZNSurrozen Inc.58,624$1.7M
KPTIKaryopharm Therapeutics Inc.299,974$1.7M
ANABANAPTYSBIO, INC27,089$1.5M
BVSBioventus Inc.159,110$1.5M
AGLagilon health inc.176,588$1.4M
RAREUltragenyx Pharmaceutical Inc.62,575$1.3M
EVMNEvommune, Inc.54,680$1.3M
IMCRImmunocore Holdings plc39,238$1.2M
ASMBASSEMBLY BIOSCIENCES, INC.40,889$1.1M
PLRXPLIANT THERAPEUTICS, INC.891,425$1.1M
SPRYARS Pharmaceuticals, Inc.136,235$1.1M
WHWKWhitehawk Therapeutics, Inc.306,800$1.1M
TYRATyra Biosciences, Inc.27,055$1.0M
BCYCBICYCLE THERAPEUTICS PLC190,715$885K
EDITEditas Medicine, Inc.290,919$719K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.